BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 417993)

  • 1. Juvenile Sandhoff Disease: complementation tests with Sandhoff and Tay-Sachs disease using polyethylene glycol-induced cell fusion.
    Wood S
    Hum Genet; 1978 Apr; 41(3):325-9. PubMed ID: 417993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tay-Sachs and Sandhoff-Jatzkewitz diseases: complementation of hexosaminidase A deficiency by somatic cell hybridization.
    Rattazzi MC; Brown JA; Davidson RG; Shows TB
    Birth Defects Orig Artic Ser; 1975; 11(3):232-5. PubMed ID: 812568
    [No Abstract]   [Full Text] [Related]  

  • 3. Juvenile Sandhoff disease: some properties of the residual hexosaminidase in cultured fibroblasts.
    Wood S; MacDougall BG
    Am J Hum Genet; 1976 Sep; 28(5):489-95. PubMed ID: 10724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on complementation of beta hexosaminidase deficiency in human GM2 gangliosidosis.
    Rattazzi MC; Brown JA; Davidson RG; Shows TB
    Am J Hum Genet; 1976 Mar; 28(2):143-54. PubMed ID: 817596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Genetic study of GM2 gangliosidosis (Tay-Sachs and Sandhoff) by the study of the hexosaminidases of the Sandhoff-rodents hybrids (mouse and hamster)].
    Weil D; Van Cong N; Rebourcet R; Frézal J
    Ann Genet; 1975 Sep; 18(3):163-8. PubMed ID: 810067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The mutation mechanism causing juvenile-onset Tay-Sachs disease among Lebanese.
    Hechtman P; Boulay B; Bayleran J; Andermann E
    Clin Genet; 1989 May; 35(5):364-75. PubMed ID: 2527097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic complementation after fusion of Tay-Sachs and Sandhoff cells.
    Thomas GH; Taylor HA; Miller CS; Axelman J; Migeon BR
    Nature; 1974 Aug; 250(467):580-2. PubMed ID: 4367631
    [No Abstract]   [Full Text] [Related]  

  • 8. Sandhoff disease: impaired catabolism of sulfated glycosaminoglycans in cultured fibroblasts.
    Cantz M; O'Brien JF; Kresse H
    Birth Defects Orig Artic Ser; 1975; 11(6):261-7. PubMed ID: 127630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tay-Sachs and Sandhoff diseases: an hypothesis about the primary lesion based on hexosaminidase patterns in interspecific hybrids.
    Van Cong N; Weil D; Rebourcet R; Pangalos C; Frézal J
    Birth Defects Orig Artic Ser; 1975; 11(3):272-5. PubMed ID: 812570
    [No Abstract]   [Full Text] [Related]  

  • 10. Detection of GM2-gangliosidosis (Tay-Sachs and Sandhoff disease) gene carriers by serum hexosaminidase assay.
    Molzer B; Bernheimer H
    Clin Chim Acta; 1976 Nov; 73(1):163-9. PubMed ID: 826357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The expression of hex A and hex B isozymes of hexosaminidase in parental and experimental human fibroblast cells and their components.
    Bladon MT
    Biochem Genet; 1981 Oct; 19(9-10):971-86. PubMed ID: 7332532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Segregation of Tay-Sachs and Sandhoff alleles in a non-Jewish family.
    Lane AB; Young E; Jenkins T
    Am J Hum Genet; 1980 Nov; 32(6):920-6. PubMed ID: 7446530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apoptotic cell death in mouse models of GM2 gangliosidosis and observations on human Tay-Sachs and Sandhoff diseases.
    Huang JQ; Trasler JM; Igdoura S; Michaud J; Hanal N; Gravel RA
    Hum Mol Genet; 1997 Oct; 6(11):1879-85. PubMed ID: 9302266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A study of hexosaminadases in interspecific hybrids and in GM2 gangliosidosis with a discussion on their genetic control.
    Van Cong N; Weil D; Rebourcet R; Frézal J; Richard-Mollard AM
    Ann Hum Genet; 1975 Jul; 39(1):111-23. PubMed ID: 810068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for a hybrid hexosaminidase isoenzyme in heterozygotes for Sandhoff disease.
    Lowden JA
    Am J Hum Genet; 1979 May; 31(3):281-9. PubMed ID: 463876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alpha-locus hexosaminidase genetic compound with juvenile gangliosidosis phenotype: clinical, genetic, and biochemical studies.
    Johnson WG; Cohen CS; Miranda AF; Waran SP; Chutorian AM
    Am J Hum Genet; 1980 Jul; 32(4):508-18. PubMed ID: 6772023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complementation after fusion of Sandhoff- and Tay-Sachs fibroblasts.
    Ropers HH; Grzeschik KH; Bühler E
    Humangenetik; 1975; 26(2):117-21. PubMed ID: 803466
    [No Abstract]   [Full Text] [Related]  

  • 18. A novel gene editing system to treat both Tay-Sachs and Sandhoff diseases.
    Ou L; Przybilla MJ; Tăbăran AF; Overn P; O'Sullivan MG; Jiang X; Sidhu R; Kell PJ; Ory DS; Whitley CB
    Gene Ther; 2020 May; 27(5):226-236. PubMed ID: 31896760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carrier detection in Sandhoff disease.
    Lowden JA; Ives EJ; Keene DL; Burton AL; Skomorowski MA; Howard F
    Am J Hum Genet; 1978 Jan; 30(1):38-45. PubMed ID: 414620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Reconstruction of hexosaminidase isoenzymes during hybridization of fibroblasts from Tay-Sachs and Sandhoff diseases].
    Beĭer EM; Vidershaĭn GIa; Venert M
    Biull Eksp Biol Med; 1984 Jan; 97(1):83-6. PubMed ID: 6229294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.